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In this work, a new sensitive analytical method has been developed and evaluated for the determination of the most commonly
used gaseous anesthetics, desflurane, sevoflurane, and this latter’s hepatic metabolite hexafluoroisopropanol (HFIP) in the urine. In
addition, an evaluation of anesthetics exposition on the urine levels of a small population of surgical operators has been performed
and results are briefly discussed.
1. Introduction
Halogenated anesthetics are important risk factors in occupa-
tional medicine field. Indeed, while their short-term effects
for acute exposure are well known [1, 2] and some fatal
cases [2–5] have been reported, chronicle exposures to these
xenobiotics are not studied yet, even if toxic effects (abortion
and liver damage) are suspected in people involved in these
jobs. In addition, scientific research is leading to the devel-
opment of protocols in which the use of anesthetic mixtures
reduces their concentration; on the other hand, these require
more sensitivity and selective analytical methods for their
determination.
Inhalation anesthesia is indeed a widely used method for
inducing complete anesthesia in surgeries. Several collateral
or secondary effects due to acute exposure to inhalatory
anesthetics are reported in the literature [1, 2, 6], while little
information has been collected on chronicle exposure to
small amounts of these drugs. Nowadays, the most represen-
tative class of anesthetics used is perfluorinated molecules
such as desflurane and sevoflurane.These drugs are very often
employed in synergy with nitrogen dioxide and sometimes
with other anesthetics in order to reduce doses and anesthetic
induction times.
The surgical operators exposure to the drugs is today
drastically reduced due to the use of efficient air recirculation
and refreshing systems in the surgical theatres and the
development of anesthesia protocols. Nevertheless, symp-
toms such as drowsiness, reduction of concentration, and
lack of clarity are sometimes still reported from operators,
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requiring a more effective control on working areas in
order to reduce risks directly or indirectly connected to the
inhalatory anesthetics use.
In order to establish if an effective amount of anesthetic is
inhaled from operators, a very sensitive technique is required
to determine the concentration of anesthetic in surgical
theatres since a relatively small xenobiotics concentration is
required to improve the working conditions.
While first approaches to determine anesthetics were
based on hexane extraction [7, 8], more recently, gas chro-
matography (GC) equipped with different kinds of detectors
has been used to identify these drugs [9–14].Themost recent
method relies on rapid determination of sevoflurane and hex-
afluoroisopropanol (free, unconjugated form) based on direct
injection of human plasma into GC/MS apparatus without
any sample clean-up procedures [15]. Indeed, GC/MS tech-
nique is nowadays a very common analysis tool and its field
of application can be extended to moderately polar to very
polar molecules by appropriate derivatization/modification
procedures [16, 17].
In our work, a very sensitivemethod based on solid phase
microextraction gas chromatography mass spectrometry for
determination of anesthetics in urine has been developed.
The analysis results were also evaluated in the light
of independent environmental anesthetics determinations
obtained through a complementary technique based on the
photo-acoustic detection principle [18].
In particular, sevoflurane, its metabolite hexafluoroiso-
propyl alcohol, and desflurane were taken into consideration
(Figure 1), using halothane as internal standard and matrix
matched calibration curves.
This approach took into consideration the matrix effect,
which also, in our case, proved to be relevant especially
when SPME was used. Due to its high sensitivity, rapidity,
and the simultaneous determination of different anesthetics
in urine samples, the present method represents a further
development in comparison with the literature [19–21].
2. Experimental
2.1. Reagents and Materials. Water (HPLC grade), meth-
anol (HPLC grade), 𝛽-glucuronidase from bovine liver
(≥1,000,000 units/g solid), and sodium chloride were pur-
chased from Sigma-Aldrich (Supelco, Bellafonte).
SPME experiments were carried out using three kinds
of coated fibers: 100 𝜇m PDMS, 65 𝜇m PDMS/CAR, and
50/30 𝜇m DVB/CAR/PDMS. These fibers were purchased
from Sigma-Aldrich (Supelco, Bellafonte).
2.2. Standards, Internal Standards, and Stock Solutions. Sev-
oflurane (99,9%) and desflurane (99,8%) were purchased
from Baxter (Deerfield, IL); halothane (99,5%) and hexaflu-
oroisopropyl alcohol (99%) were purchased from Sigma-
Aldrich (Supelco, Bellafonte). Standard solutions preparation
was made according to this procedure: 20𝜇L aliquots of
sevoflurane, desflurane, and hexafluoroisopropanol (HFIP)
were weighed and dissolved in methanol in 100mL flasks.
Due to their high volatility, for all analytes (sevoflurane,
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Figure 1: Structures of halogenated anesthetics determined sevoflu-
rane and desflurane, of sevoflurane’s metabolite hexafluoroisopropyl
alcohol, and of halothane (internal standard).
boiling point: 331.75 K at 101.3 kPa and density 1.5 × 103 kg/m3
at 293K; desflurane, boiling point: 296.65 K at 101.3 kPa and
density 1.5 × 103 kg/m3 at 293K; HFIP, boiling point: 332 K at
101.3 kPa and density 1.6× 103 kg/m3 at 293K), pure standards
volumes were picked through cold (255K) tips and were
rapidly weighed into volumetric flasks containing 10mL of
cold methanol.
These solutions were then diluted with a further amount
of cold methanol (255K) up to the mark (100mL) at ambient
temperature (298K).
The solutions obtained had a final concentration of
302 𝜇gmL−1 for desflurane and sevoflurane and 320𝜇gmL−1
for HFIP. These stock solutions, stored in refrigerator at
277K ± 2K, were checked weekly and were found to be stable
in these conditions up to three months.
An aqueousmother solution containing all the analytes at
a concentration of 250𝜇g L−1 has been prepared using these
standard solutions and it has been found stable for no more
than a month. Further diluted solutions, used to make the
matrix matched calibration curves, were prepared weekly by
simple dilution of the mother solution in HPLC grade water.
Internal standard solution was prepared picking 20 𝜇L
of halothane standard (density 1,86 × 103 kg/m3 at 293K)
through cold (255K) tips and rapidly weighing into volumet-
ric flasks containing a small amount of cold methanol (about
10mL at 293K).
The obtained solution was then further diluted up to
the mark (100mL) with methanol at ambient temperature
(298K). The solution obtained has a final concentration of
380 𝜇gmL−1 and was stored in refrigerator at 277K ± 2K.
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Figure 2: Rationale of the fragmentation processes explaining the selected peaks for the SIM analysis.
This solutionwas checkedweekly and it was found to be stable
in these conditions up to three months.
2.3. Apparatus. Analyses were carried out using Focus GC
Thermo equipped with a capillary column Supel Q-Plot
(30m × 0.32mm I.D. × 15 𝜇m average thickness), coupled
with a DSQ II Mass Spectrometer, working in selected ions
monitoring (SIM)mode.The analysis method was optimized
in order to reach the maximum efficacy in terms of rapidity,
selectivity, and sensitivity.
The best trade-off obtained leads to a total analysis
time of 13 minutes (see Figure 2). Operating conditions
were the following: injector temperature, 473K; splitless (gas
flow 1mLmin−1, splitless flow for 1min with a gas flow
10mLmin−1); constant flow 1mLmin−1; and carrier gas,
helium. The thermal program starts at 309K and holds for
3min and then the temperature increases at 40Kmin−1 up to
403K and holds for 7 minutes at this temperature.
According to the literature and the experimental data
obtained from pure standards full scan MS spectra, the most
representative mass peaks have been chosen (see Table 1).
These ions were used in SIM mode in order to increase
sensitivity, with respect to full scan MS.
The rationale fragmentation processes that could explain
these peaks are briefly reported in Figure 2.
2.4. Samples Preparation. The following procedure was
applied for the real samples preparation: 18mL sealed
vials were prepared with 1mL of enzyme solution (𝛽-
glucuronidase 999Ui/mL), 10 𝜇L of acetic acid, 40 𝜇L of
internal standard solution, and 2.0 × 10−3 kg of NaCl. 3950 𝜇L
of surgery’s operator urine was added by means of gastight
syringe into the previously prepared vials. In order to avoid
Table 1: Selected ions for SIM analysis.
Anesthetic Selected ions (m/z)
Desflurane 51; 69; 101
Sevoflurane 69; 131; 181
HFIP 79; 99; 129
Halothane 117; 127; 196
loss in IS concentration, the urine volumes were placed into
the vials, without unscrewing the cap and piercing the septum
with the syringe’s needle. After having placed the vials at 310K
for 16 h to obtain the enzymatic hydrolysis of the glucuronate-
HFIP, the samples were analyzed.
Matrix matched calibration samples were prepared
weekly according to the following procedure: 1mL of enzyme
solution (𝛽-glucuronidase 999Ui/mL), 10 𝜇L of acetic acid
in order to generate the optimal conditions (pH 4-5) for
the enzyme activation, 40𝜇L of internal standard solution,
1mL of standard solution containing the mix of anesthetics
at increasing concentration, and an aliquot of urine (pooled
50% from female and 50% from male voluntary healthy
subjects) up to final volume of 5mL were added in a 18mL
vial, sealed with PTFE/silicon septum; finally, in order to
get a salting-out effect, 2.0 × 10−3 kg of NaCl was added.
For the sake of strict repeatability, standards were subjected
to 16 hours of incubation at 310 K (normally necessary for
the enzymatic hydrolysis of the glucuronate-HFIP) before
analysis.
2.5. Solid Phase Microextraction Procedures (SPME). SPME
technique required a preliminary study to determine the
most straightforward extraction procedure. The final opti-
mal conditions were the following: fiber DVB/CAR/PDMS;
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Figure 3: SPME sampling procedure scheme.
equilibration time (T1): 30 minutes (298K ± 1 K); extraction
time (T2): 10 minutes (298K ± 1 K).The best fiber desorption
conditions were the following: injector at 473K, desorption
time (T3) of 1 minute (splitless mode). See Figure 3.
2.6. Environmental Monitoring and Real Samples Collection.
Anesthetic concentrations in different selected operating
rooms were measured by Multi-Gas monitor Type 1302
(Bru¨el & Kjær, Denmark), whose design was based on
the photo-acoustic detection principle. This instrument is
capable of continuously recording the gaseous concentrations
of fluorinated anesthetics within the surgery room.
More than 25 real samples were collected from operators
working in three different surgical rooms. Analyses were
carried out in duplicate on pre- and post shift urine samples
of both the operators coming in contact with the anesthetics
during their shift (i.e., surgeons or anesthetists) and the ones
that are not usually in contact with xenobiotics during shift
(i.e., medical attendants).
3. Results and Discussion
3.1. Method Optimization. Solid phase microextraction is a
sample preparation method, invented by Pawliszyn in 1989,
which does not require solvents. Since its first applications to
environmental and food analysis, its use is becoming wider
and frequent, due to its environmentally friendly features,
effectiveness, and reduced costs. The principle of SPME is
based on a fused-silica fiber that is coated with an appropriate
stationary phase. All analytes in the sample are directly
extracted to the fibre coating, in a single step that involve both
extraction and concentration from the headspace of the vial.
Because of the high volatility of the compounds, opti-
mizing the efficiency and sensitivity of the analysis method
is necessary to identify the most suitable SPME sampling
conditions. The first step in the development of a SPME
method was the fiber selection. Therefore, three different
SPME fibers (PDMS; PDMS/CAR; DVB/CAR/PDMS) have
been tested.The analyte peak areas, obtained from analyses of
standard solutions at the same concentration of anesthetics,
were compared and the higher efficiency of extraction of all
the analytes was reached using the DVB/CAR/PDMS fiber
(according also to Poli et al., 1999). See Figure 4.
The second step was the determination of the optimal
saturation time, needed for the analytes to reach equilib-
rium between the matrix, the headspace, and the fiber. The
headspace sampling was performed at the same temperature
(298K ± 1 K) for all the analytes and optimal saturation time
was determined; the analyte peak areas after 15, 30, and 60
minutes of equilibration were compared, showing that 30
minutes were enough to reach equilibrium in headspace.
Finally, in order to improve the extraction efficiency, various
extraction timeswere evaluated.The comparison between the
responses obtained from extraction times of 5, 10, 20, and 30
minutes, at the same temperature (298K ± 1 K), indicates that
after 10 minutes the extraction efficiency reached a plateau.
No further raise in analyte peak areas resulted from
increase of the fiber exposition time in HS.
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Figure 4: Internal standard (halothane) peaks obtained with three different types of fibers. The most efficient extraction has been obtained
through DVB/CAR/PDMS fiber.
3.2. Calibration Curves and Method Performance Evaluation.
A preliminary calibration curve was made in water in order
to achieve the order of magnitude of both limit of detection
(LOD) and limit of quantification (LOQ) and to verify the
linearity range of the whole method without any interference
due tomatrix.These provided a very strong linear correlation
(R2 > 0.99) in a range from 0.32 𝜇g L−1 to 40 𝜇g L−1. GC/MS
chromatogramof 5 𝜇g L−1 fortified (a) and blank (b) urine are
reported in Figure 5 to show analytes separation and method
sensitivity in matrix.
The effect of the matrix has been evaluated in order to
verify its eventual impact on linearity, sensitivity, and slope
of the calibration curves using matrix matched calibration
curves to determine effects of the matrix at different levels of
concentration.
Indeed SPME analysis is quite prone to matrix effect
repercussions on calibration curves. In addition, in our
experience, the intrinsic low reproducibility of precise exper-
imental conditions (i.e., intrinsic sample differences, fiber
wearing, etc.) often requires an internal standard to effectively
reduce errors. When a matrix effect is observed, as in this
case, both amatrixmatched calibration curve and an internal
standard should be used in order to reduce errors and
improve the accuracy of themeasures. As shown in Figure 6, a
markedmatrix effect is observed when determining the same
anesthetic concentration in water and urine. Indeed, very
different (sample/internal standard) area ratios are observed
looking at “calibration curves” obtained in distilled water
(inserts) and calibration curves made using pooled urine as
matrix. This matrix effect markedly lowers the calibration
curve slopes (and consequently the sensitivity) with respect
to calibration curves obtained in pure water. This defeats
any attempt to use an external calibration and requires
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Figure 5: GC/MS chromatogram of fortified urine at 5 𝜇g L−1 (a)
and blank (b) urine.
a matrix effect correction. However, matrix matched calibra-
tion curves repeated using different urine pools at distance of
one to several weeks demonstrate good reproducibility, with
similar slopes and intercepts. This demonstrates that matrix
effect is not peculiar for each sample and does not require
more complicated and time consuming multiple standard
addition procedures in order to get reliable measures.
The linearity of the method using matrix matched stan-
dards remains fair, even if it has been ascertained in a range of
concentration that is smaller (from 0.30𝜇g L−1 to 22.5 𝜇g L−1
for sevoflurane and desflurane and in the range 0.32 𝜇g L−1
to 24𝜇g L−1 for HFIP) than the corresponding linearity
obtained in water solution (from 0.06𝜇g L−1 to 37.5 𝜇g L−1
for sevoflurane and desflurane and in the range 0.6𝜇g L−1 to
40 𝜇g L−1 for HFIP; see Figure 6) standards.
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Figure 6: Matrix matched calibration curves for desflurane (a),
sevoflurane (b), and HFIP (c) in the insert are reported as the
corresponding curves in water.
The three curves obtainedwere weighed on 1/x in order to
enhance the curve fitting at a lower concentration and show
a very good coefficient of correlation R2 (see Table 2).
Also LOD and LOQ have been calculated according to
this procedure: average and standard deviation values of at
least 20 blanks have been reckoned and LOD and LOQ values
are defined as blanks signal average plus 3 and 10 times the
standard deviation of the blanks, respectively.
The following performances studies were, moreover, car-
ried out: within-laboratory repeatability (WLr) and within-
laboratory reproducibility (WLR) expressed as % RSD on
sample at 5.0 𝜇g L−1 (see Table 2).
3.3. Cases Study Results. Theextended performances reached
through this method were useful to evaluate the anesthetic
exposure effects on a small number of operators working in
surgical theaters. In the selected theaters, a parallel evaluation
of the environmental instantaneous levels of anesthetic was
also conducted in order to evaluate eventual relationships
between the “environmental pollution” and the anesthetics
biological levels. The observed correlation was indeed scarce
Table 2: Method performances.
Analyte LOD(𝜇g L−1)
LOQ
(𝜇g L−1)
𝑅2 (weighed
1/𝑥) WLr WLR
Desflurane 0.015 0.022 0.996 9.90% 11.50%
Sevoflurane 0.022 0.039 0.994 11.60% 12.47%
HFIP 0.024 0.042 0.996 2.71% 14.22%
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Figure 7: Spread of urinary level increments of desflurane for the
different surgery rooms (◻ squares: oncology;󳵻 triangles: emergen-
cy A; I circles: emergency B).
and no correlation was found between the exposition time
and the anesthetics biological levels. Actually, it emerged that,
during the surgical operations,the staff exposition time to
anesthetics is largely variable and not linked to the work-
ing hours. Another exposition factor such as the distance
between the vaporizer and each individual is variable as well.
Thus, a correlation between environmental pollution and
urine levels should not be expected. However, a variation in
urine levels of anesthetics has been definitely ascertained.
The samples collected from operators working in three
different surgical theaters were used to determine desflurane
levels, while those collected from the other two surgical
theaters were employed to determine the sevoflurane levels
and its metabolite HFIP in urine. It is worth noting that, in
all cases, the anesthetics levels determined after shift were
higher than the corresponding levels in pre-shift samples. In
particular, high levels of desflurane anesthetic were deter-
mined in people working in emergency B surgical theaters.
Fromanamnesis, it was ascertained that several peoplemostly
working in this theatre reported symptoms such as headache,
drowsiness, asthenia, and concentration diseases, while the
same diseases were rarely found in people working in the
other theaters. Urine levels can be taken as a clue of the air
condition system efficiency being mean levels of anesthetics
well grouped for each surgical theatre; see Figure 7. It is also
interesting to note that levels before and after shift were
in the 𝜇g L−1 order, mostly corresponding to the LODs of
the previously reported methods [19, 20]. This implies that,
in most cases, up to now, only few positive cases could be
detected, of subject being exposed to anesthetics. From our
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determinations, instead, it seems that, even if in different
extents, exposition to anesthetics involves all the personnel
working in the theatres. Indeed, post-shift urine mean levels
were always significantly higher than pre-shift ones.
4. Conclusions
The developed analytical method proved to be very quick,
sensitive, and robust (precision, calculated asRSD,was always
below 13% for all intra- and interday determinations). Sample
preparation is simple and can be performed even by not
highly specialized personnel.
It represents a further development in comparison with
the literature being the first method for the quantification of
desflurane in biological fluids. Indeed, this method exhibits
LOD and LOQ values at least 2 magnitude orders lower
than those previously reported [19–21] for similar volatile
anaesthetics. This is probably due to the synergism of a well-
optimized SPME procedure and GC/SIM-MS analysis. The
preliminary data obtained by this pilot study on surgical the-
atres stressed the effectiveness of this method as a useful tool
to monitor the exposition to anaesthetics in occupationally
exposed people.
Indeed, with thismethod, it has been possible to ascertain
significant difference between the anesthetics levels in urine
before and after the work shifts in 25 individuals. Further,
significant differences in post-shift urine levels have been
found in personnelworking in different surgical theaters.This
means that different working conditions and probably differ-
ences in efficiency of the environmental treatment effectively
reflect on personnel exposition to these xenobiotics.
Conflict of Interests
The authors declare that there is no conflict of interests
regarding the publication of this paper.
Acknowledgment
The “Fondi ricerca scientifica ex 60% Universita` di Palermo”
is gratefully acknowledged for financial support.
References
[1] M. Adachi, Y. Ikemoto, K. Kubo, and C. Takuma, “Seizure-like
movements during induction of anaesthesia with sevoflurane,”
British Journal of Anaesthesia, vol. 68, no. 2, pp. 214–215, 1992.
[2] J. J. Kuhlman Jr., B. Levine, M. L. Smith, and J. R. Hordinsky,
“Toxicological findings in Federal Aviation Administration
general aviation accidents,” Journal of Forensic Sciences, vol. 36,
no. 4, pp. 1121–1128, 1991.
[3] M. Yamashita, A. Matsuki, and T. Oyama, “Illicit use of modern
volatile anaesthetics,” Canadian Anaesthetists Society Journal,
vol. 31, no. 1, pp. 76–79, 1984.
[4] C. W. Sharp and M. L. Brehm, Eds., Review of Inhalants:
Euphoria to Dysfunction, vol. 102 of Nida Research Monograph
15, 1977.
[5] B. Jacob, C. Heller, T. Daldrup, K. F. Burrig, J. Barz, and
W. Bonte, “Fatal accidental enflurane intoxication,” Journal of
Forensic Sciences, vol. 34, no. 6, pp. 1408–1412, 1989.
[6] C. Edling, “Anesthetic gases as an occupational hazard. A
review,” Scandinavian Journal ofWork, Environment andHealth,
vol. 6, no. 2, pp. 85–93, 1980.
[7] W. Toner, P. J. Howard, and M. G. Scott, “Estimation of
blood enflurane concentrations by gas-liquid chromatography,”
British Journal of Anaesthesia, vol. 49, no. 9, pp. 871–873, 1977.
[8] M. S. Miller and A. J. Gandolfi, “A rapid, sensitive method for
quantifying enflurane in whole blood,” Anesthesiology, vol. 51,
no. 6, pp. 542–544, 1979.
[9] J. Flynn, S. Masud, J. D. O’Keeffe, W. S. Wren, and I. M.
Shanahan, “Gas chromatographic determination of volatile
anaesthetic agents in blood. Part 2. Clinical studies,” Analyst,
vol. 114, no. 10, pp. 1211–1213, 1989.
[10] O. L. de Guevara, A. A. Godoy, and C. C. De Nava, “Quantifi-
cation of halothane, enflurane and nitrous oxide by means of a
simple gas chromatographic method,” Journal of Chromatogra-
phy A, vol. 403, pp. 350–354, 1987.
[11] W. M. Gray, “A static calibration method for the gas chromato-
graphic determination of per cent concentrations of volatile
anaesthetic agents,” British Journal of Anaesthesia, vol. 58, no.
3, pp. 345–352, 1986.
[12] H. Heusler, “Quantitative analysis of common anaesthetic
agents,” Journal of Chromatography, vol. 340, pp. 273–319, 1985.
[13] N. C. Yang, K. L. Hwang, C. H. Shen, H. F. Wang, and W.
M. Ho, “Simultaneous determination of fluorinated inhalation
anesthetics in blood by gas chromatography-mass spectrometry
combined with a headspace autosampler,” Journal of Chro-
matography B, vol. 759, no. 2, pp. 307–318, 2001.
[14] T. Kojima, A. Ishii, K. Watanabe-Suzuki et al., “Sensitive deter-
mination of four general anaesthetics in human whole blood
by capillary gas chromatographywith cryogenic oven trapping,”
Journal of Chromatography B, vol. 762, no. 1, pp. 103–108, 2001.
[15] J. Kubincova´a, A. Szabo´ova´a, P. Podoleca et al., “Determination
of sevoflurane and its metabolite hexafluoroisopropanol by
direct injection of human plasma into gas chromatography-
tandem mass spectrometry,” Journal of Chromatography A, vol.
1219, pp. 173–176, 2012.
[16] M. L. Di Gioia, A. Leggio, A. Le Pera et al., “Determination by
gas chromatography/mass spectrometry of p-phenylenediam-
ine in hair dyes after conversion to an imine derivative,” Journal
of Chromatography A, vol. 1066, no. 1-2, pp. 143–148, 2005.
[17] M. L. Di Gioia, A. Leggio, A. Le Pera et al., “‘One-pot’ methyla-
tion of N-nosyl-𝛼-amino acid methyl esters with diazomethane
and their coupling to prepare N-methyl dipeptides,” Journal of
Organic Chemistry, vol. 68, no. 19, pp. 7416–7421, 2003.
[18] B. Walder, R. Lauber, and A. M. Zbinden, “Accuracy and cross-
sensitivity of 10 different anesthetic gas monitors,” Journal of
Clinical Monitoring, vol. 9, no. 5, pp. 364–373, 1993.
[19] A. Accorsi, B. Morrone, M. Benzo, C. Gandini, G. B. Raffi,
and F. S. Violante, “Simultaneous determination of unmodified
sevoflurane and of its metabolite hexafluoroisopropanol in
urine by headspace sorptive extraction-thermal desorption-
capillary gas chromatography-mass spectrometry,” Journal of
Chromatography A, vol. 1071, no. 1-2, pp. 131–134, 2005.
8 Journal of Analytical Methods in Chemistry
[20] A. Accorsi, S. Valenti, A. Barbieri, G. B. Raffi, and F. S. Violante,
“Enflurane as an internal standard in monitoring halogenated
volatile anaesthetics by headspace gas chromatography-mass
spectrometry,” Journal of Chromatography A, vol. 985, no. 1-2,
pp. 259–264, 2003.
[21] D. Poli, E. Bergamaschi, P. Manini, R. Andreoli, and A. Mutti,
“Solid-phase microextraction gas chromatographic-mass spec-
trometric method for the determination of inhalation anesthet-
ics in urine,” Journal of Chromatography B, vol. 732, no. 1, pp.
115–125, 1999.
Submit your manuscripts at
http://www.hindawi.com
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Inorganic Chemistry
International Journal of
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2013
 International Journal ofPhotoenergy
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Carbohydrate 
Chemistry
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Chemistry
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Advances in
Physical Chemistry
Hindawi Publishing Corporation
http://www.hindawi.com
 Analytical Methods 
in Chemistry
Journal of
Volume 2014
Bioinorganic Chemistry 
and Applications
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Spectroscopy
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Medicinal Chemistry
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Chromatography  
Research International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Applied Chemistry
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Theoretical Chemistry
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Spectroscopy
Hindawi Publishing Corporation
http://www.hindawi.com
International Journal of 
Analytical Chemistry
Volume 2014
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Quantum Chemistry
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Organic Chemistry 
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Catalysts
Journal of
Electrochemistry
International Journal of
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
